Skip to main content
. 2020 Oct 12;143(4):298–309. doi: 10.1161/CIRCULATIONAHA.120.050391

Figure 2.

Figure 2.

Effect of dapagliflozin on the prespecified renal composite outcome. Renal outcome was a composite of ≥50% sustained decline estimated glomerular filtration rate or end-stage renal disease or renal death in DAPA-HF (Dapagliflozin and Prevention of Adverse-outcomes in Heart Failure). HR indicates hazard ratio.